Han Hyoung-Yun, Park Se-Myo, Ko Je-Won, Oh Jung-Hwa, Kim Sang Kyum, Kim Tae-Won
Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-Ro, Yuseong-Gu, Daejeon, 34114 Republic of Korea.
Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon, Republic of Korea.
Toxicol Res. 2022 Dec 12;39(2):201-211. doi: 10.1007/s43188-022-00156-y. eCollection 2023 Apr.
Thioacetamide (TAA) was developed as a pesticide; however, it was soon found to cause hepatic and renal toxicity. To evaluate target organ interactions during hepatotoxicity, we compared gene expression profiles in the liver and kidney after TAA treatment. Sprague-Dawley rats were treated daily with oral TAA and then sacrificed, and their tissues were evaluated for acute toxicity (30 and 100 mg/kg bw/day), 7-day (15 and 50 mg/kg bw/day), and 4-week repeated-dose toxicity (10 and 30 mg/kg). After the 4-week repeated toxicity study, total RNA was extracted from the liver and kidneys, and microarray analysis was performed. Differentially expressed genes were selected based on fold change and significance, and gene functions were analyzed using ingenuity pathway analysis. Microarray analysis showed that significantly regulated genes were involved in liver hyperplasia, renal tubule injury, and kidney failure in the TAA-treated group. Commonly regulated genes in the liver or kidney were associated with xenobiotic metabolism, lipid metabolism, and oxidative stress. We revealed changes in the molecular pathways of the target organs in response to TAA and provided information on candidate genes that can indicate TAA-induced toxicity. These results may help elucidate the underlying mechanisms of target organ interactions during TAA-induced hepatotoxicity.
The online version contains supplementary material available at 10.1007/s43188-022-00156-y.
硫代乙酰胺(TAA)最初作为一种杀虫剂开发;然而,很快就发现它会导致肝脏和肾脏毒性。为了评估肝毒性过程中靶器官的相互作用,我们比较了TAA处理后肝脏和肾脏中的基因表达谱。将Sprague-Dawley大鼠每日经口给予TAA,然后处死,对其组织进行急性毒性(30和100mg/kg体重/天)、7天(15和50mg/kg体重/天)和4周重复给药毒性(10和30mg/kg)评估。在4周重复毒性研究后,从肝脏和肾脏中提取总RNA,并进行微阵列分析。根据倍数变化和显著性选择差异表达基因,并使用 Ingenuity 通路分析对基因功能进行分析。微阵列分析表明,在TAA处理组中,显著调控的基因涉及肝脏增生、肾小管损伤和肾衰竭。肝脏或肾脏中共同调控的基因与异源物质代谢、脂质代谢和氧化应激有关。我们揭示了靶器官对TAA反应的分子途径变化,并提供了可指示TAA诱导毒性的候选基因信息。这些结果可能有助于阐明TAA诱导肝毒性过程中靶器官相互作用的潜在机制。
在线版本包含可在10.1007/s43188-022-00156-y获取的补充材料。